Reflow Medical Enrolls First Patients in Pilot Study of Coronary Sirolimus-Eluting Retrievable Scaffold System (Spur Elute)

Contributed by: Business Wire

Logo

Tags

Surgery

Medical Devices

Hospitals

Clinical Trials

Health Technology

Cardiology

Biotechnology

Health

General Health

DEEPER CORONARY

More Like This

The first and only retrievable stent system that features a self-expanding stent with an integrated dilatation balloon catheter on an over-the-wire system. It is designed for controlled lesion penetration and treatment through a series of radially expandable spikes. Known as Retrievable Scaffold Therapy (RST), the spikes on the Spur Stent penetrate the lesion to increase the acute luminal diameter and modify the lesion morphology to change vessel compliance and reduce vessel recoil effect.

FDA Grants De Novo Clearance for Reflow Medical's Spur® Peripheral Retrievable Stent System

The Bare Temporary Spur Stent System is a unique clinical solution known as Retrievable Stent Therapy, or RST. It is intended to provide stent-like results while leaving no metal behind. (Graphic: Business Wire)

Reflow Medical Receives CE Mark for Bare Temporary Spur Stent System for Treating de novo or Restenotic Below-the-Knee (BTK) Lesions

Reflow Medical Expands Global Reach with New European Subsidiary

PR Newswire associated0

MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study

PR Newswire associated0

CONCEPT MEDICAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN "MAGICAL-ISR" IDE STUDY IN THE US

PR Newswire associated0

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data

Implantica announces first RefluxStop™ public tender win, paving the way for permanent reimbursement in Italy